Gilead's remdesivir is not recommended for patients hospitalised with Covid-19, regardless of how ill they are, as there is no evidence the drug improves survival or reduces the need for ventilation, a World Health Organisation ...
Antiviral remdesivir should not be used as a routine treatment for Covid-19 patients in critical care wards, the head of one of the world's top bodies representing intensive care doctors said, in a blow to the drug developed by US firm Gilead.
A row broke out on Friday over a World Health Organization (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patient's chances of surviving Covid-19.
The European Union's executive said on Wednesday it had agreed to buy a limited supply of the Covid-19 medicine remdesivir from US drugmaker Gilead to address the short-term needs of European patients
Gilead Sciences Inc said on Friday additional data from a late-stage study showed its antiviral remdesivir reduced the risk of death and significantly improved the conditions of severely ill Covid-19 patients.
Singapore on Wednesday approved the use of Gilead Sciences Inc's antiviral drug remdesivir for the treatment of severely ill patients with Covid-19 infection.
Gilead Sciences Inc's antiviral drug, remdesivir, prevented lung disease in macaques infected with the new coronavirus, according to a study published in medical journal Nature on Tuesday.
Gilead Sciences Inc said on Monday its antiviral drug remdesivir had mixed results in a late stage study of people with moderate Covid-19, as patients given a five-day course of the treatment showed
Anti-viral drug remdesivir cuts recovery times in coronavirus patients, according to the full results of a trial published Friday night, three weeks after America's top infectious diseases expert said the study showed
Takeda Pharmaceutical Co said on Wednesday it was developing a drug for high-risk patients infected with the new coronavirus, joining several other drugmakers seeking to develop a treatment for an illness that has killed over 3,000 people.